Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoproliferative Disorders × Ondansetron × 90 days × Clear all

Sponsor

Conditions

Vulvar Neoplasms 1 Vulvar Diseases 1 Uterine Cervical Dysplasia 1 Papillomavirus Infections 1 Carcinoma, Hepatocellular 1 Carcinoma in Situ 1

Interventions

Cyclophosphamide 5 fludarabine phosphate 3 fludarabine 3 Tacrolimus 3 Rituximab 3 Mycophenolic Acid 3 Busulfan 3 acalabrutinib 2 Whole-Body Irradiation 2 Vincristine 2 Prednisone 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Mesna 2 Melphalan 2 Doxorubicin 2 Bortezomib 2 venetoclax 1 trametinib 1 obinutuzumab 1 liposomal doxorubicin 1 isatuximab 1 ibrutinib 1 dabrafenib 1 Zidovudine 1 Valganciclovir 1 Thiotepa 1 Sirolimus 1 Nivolumab 1 Lenalidomide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡